Nautilus, Creabilis therapeutic protein deal

Nautilus (Paris, France) will use its protein evolution technology to identify a variant of CT500 protein from Creabilis ( Ivrea, Italy) with an improved pharmacodynamic profile. CT500 targets HMGB1, ...